SecBot SecBot
PRESS-RELEASE ·Filed Jul 13, 2026

COSM

Cosmos Health Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago WireGlobeNewswire
Press release · Buyback
Actionable Insight • Neutral

The buyback is small relative to market cap and does not change the fundamental outlook. Monitor for any operational updates or earnings that could justify management's conviction. The program expires Dec 31, 2026 — continued repurchases at this pace would take several quarters to exhaust the remaining authorization.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
COSM ▲ +3.60% at T+60d
NEUTRAL call +3.60% · α vs SPY -0.39% · entry $0.3084 → $0.3195
Entry = T+0 close
Jul 13, 2026
via day close
T+1d
-0.42%
call -0.42% · α -0.78%
$0.3071
settled 4mo ago
T+5d
-23.87%
call -23.87% · α -23.08%
$0.2348
settled 3mo ago
T+20d
-27.53%
call -27.53% · α -30.71%
$0.2235
settled 3mo ago
T+60d
+3.60%
call +3.60% · α -0.39%
$0.3195
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Cosmos Health repurchased an additional 215,000 shares at ~$0.325/share, bringing total buyback to 4,355,000 shares for ~$901,000 under a $5M program. The buyback signals management's view that shares are undervalued, but the program is small relative to the $18M market cap and the company's fundamentals are not disclosed in this release.

Key Financial Metrics

Deal Value
$901.0K

Key Facts

  • Repurchased 215,000 shares at ~$0.325/share in the open market
  • Total repurchases now 4,355,000 shares for ~$901,000 under a $5M program
  • Program expires December 31, 2026, and may be renewed
  • CEO states shares remain undervalued relative to business potential

Financial Impact

Total buyback of ~$901K represents ~5% of $18M market cap; additional $4.1M remains authorized under the $5M program

dilutionshare count

Risk Factors

  • Buyback program is discretionary and may be suspended at any time
  • No financial results or guidance provided in this release to assess fundamental value
  • Micro-cap stock with limited liquidity — buyback impact on price may be minimal

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3326424
33 reports for COSM
Performance horizon
50% Hit rate @ T+20 3 of 6 directional calls Went positive at some point 7 of 8 best @ T+60▲ +66.26%Jul 20, 2026
Filters
Rows
Reports for COSM — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
8-K
BULLISH ★ 6/10
$0.2530awaiting T+20—$0.2360 (−6.72%)
Oct 16, 2026
11d ago
SC 13G/A
NEUTRAL ★ 3/10
$0.3250awaiting T+20—$0.2360 (−27.38%)
Oct 9, 2026
18d ago
8-K
NEUTRAL ★ 4/10
$0.3496awaiting T+20—$0.2360 (−32.49%)
Sep 3, 2026
7w ago
Press Release
BEARISH ★ 6/10
$0.2660 $0.4300▼ −61.65%▼ −62.77%$0.2360 (+11.28%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$0.1930awaiting T+20—$0.2360 (−22.28%)
Jul 20, 2026
14w ago
Press Release
BULLISH ★ 4/10
$0.2303 $0.2050▼ −10.99%▼ −15.11%$0.2360 (+2.48%)
Jul 17, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2348 $0.2179▼ −7.20%▼ −11.64%$0.2360 (+0.51%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2807 $0.2065▼ −26.43%▼ −30.05%$0.2360 (−15.92%)
Jul 15, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$0.2785 $0.2071▼ −25.64%▼ −27.98%$0.2360 (−15.26%)
Jul 14, 2026
15w ago
Press Release
NEUTRAL ★ 3/10
$0.3071 $0.2198▼ −28.43%▼ −30.92%$0.2360 (−23.15%)
Showing 10 of 33

US Market Status

Market Closed — Opens Thu (11h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 13, 2026